Published in:
01-05-2021 | Chromosomal Abnormality | Maternal-Fetal Medicine
Prenatal tests for chromosomal abnormalities detection (PTCAD): pregnant women’s knowledge in an Italian Population
Authors:
Paola Quaresima, Federica Visconti, Elena Greco, Roberta Venturella, Costantino Di Carlo
Published in:
Archives of Gynecology and Obstetrics
|
Issue 5/2021
Login to get access
Abstract
Background
Nowadays several Prenatal Tests for Chromosomal Abnormalities Detection (PTCAD) are available. In those cases in which there is not an Institutional protocol to advise women about the available PTCAD, the choice of which one to undergo is up to the woman and largely depends on her knowledge about them. Therefore, we decided to evaluate, as a primary outcome, knowledge about PTCAD among pregnant women attending our Term Clinic. As a secondary outcome we evaluated the relationship between the patient’s knowledge and the subsequently chosen PTCAD.
Methods
From August 2017 to August 2018 an anonymous questionnaire with multiple-choice answers was administered to all pregnant women attending our Term antenatal Clinic, a tertiary obstetric unit in Catanzaro (Italy).
Results
Three hundred and twenty-five pregnant women were enrolled in the study. We observed that 28.8% of the pregnant women that chose one of the PTCAD, avoided the first trimester combined screening test; among these, 11.4% were in favour of the cell-free foetal DNA test. The latter was erroneously considered diagnostic by 34.3% of the women that had chosen it.
Conclusions
This study demonstrated that women’s knowledge about PTCAD is poor and that there is a potentially dangerous confusion between the words ‘screening’ and ‘diagnostic’. Informative campaigns about PTCAD and the application of dedicated antenatal counselling appointments should be a health-care priority to avoid unnecessary risks and costs for pregnant women and possible legal issues.